Betaseron to Offer the Thinnest Needle in Multiple Sclerosis

Wayne, New Jersey, September 15, 2008 - Bayer HealthCare Pharmaceuticals Inc. today announced th...  More »

Wayne, New Jersey, September 15, 2008 - Bayer HealthCare Pharmaceuticals Inc. today announced that Betaseron (interferon beta-1b), its treatment for relapsing forms of multiple sclerosis (MS), will soon be available with a new 30-gauge needle, which will be the thinnest needle of any injectable disease-modifying therapy for people with MS. The new needle is as thin as the needle commonly used for insulin and pediatric injections.  « Less